Last reviewed · How we verify
Glucose lowering medication
At a glance
| Generic name | Glucose lowering medication |
|---|---|
| Sponsor | Slotervaart Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- PROGAIN Trial in Gastric Cancer Surgery (PHASE3)
- Vascular Complications in Patients Undergoing Peripheral Revascularization and Taking SGLT-2 Inhibitors
- A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
- Metformin Safety and Efficacy in Osteoarthritis. (PHASE3)
- Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF
- Impact of Multi-Component Interventions on High Risk COPD Population (NA)
- Impact of Multi-Component Intervention on Suspected Asthma Population (NA)
- Impact of Multi-Component Interventions on High-Risk COPD Smokers (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |